Financhill
Back

Guardant Health 10K Form

Sell
46

GH
Guardant Health

Last Price:
31.94
Seasonality Move:
15.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GH News And Ratings

See the #1 stock for the next 7 days that we like better than GH

GH Financial Statistics

Sales & Book Value

Annual Sales: $373.65M
Cash Flow: $-99.89M
Price / Cash Flow: 0
Annual Sales: $1.63
Price / Book: 19.62

Profitability

EPS (TTM): -5.93000
Net Income (TTM): $-605.57M
Gross Margin: $250.74M
Return on Equity: -127.58%
Return on Assets: -29.93%

Guardant Health Earnings Forecast

Key Guardant Health Financial Ratios

  • The Gross Profit Margin over the past 6 years for GH is 67.11%.
  • The Selling, General & Administrative Expenses for GH have been equal to 106.66% of Gross Profit Margin.
  • The Research & Development expenses have been 70.45% of Revenue.
  • The Interest Expense is -0.64% of Operating Income.
  • The Net Earning history of GH is -108.57% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Guardant Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostics & Research
Sector: Healthcare
Current Symbol: GH
CUSIP: 40131M
Website: guardanthealth.com

Debt

Debt-to-Equity Ratio: 6.82
Current Ratio: 6.46
Quick Ratio: 5.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GH Technical Analysis vs Fundamental Analysis

Sell
46
Guardant Health (GH) is a Sell

Is Guardant Health a Buy or a Sell?

  • Guardant Health stock is rated a Sell
    The current Guardant Health [GH] share price is $31.94. The Score for GH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.